To strengthen the diagnosis and treatment of male breast cancer in China
10.3760/cma.j.issn.1674-6090.2018.02.001
- VernacularTitle:关注我国男性乳腺癌的诊治
- Author:
Lingquan KONG
1
;
Yutuan WU
;
Hongyuan LI
;
Guosheng REN
;
Kainan WU
Author Information
1. 400016,重庆医科大学附属第一医院内分泌乳腺外科
- Keywords:
Male breast cancer;
Diagnosis;
Treatment
- From:
Chinese Journal of Endocrine Surgery
2018;12(2):89-91
- CountryChina
- Language:Chinese
-
Abstract:
Male breast cancer is a rare disease with an incidence of about 1％ of breast cancers in USA,and about 1.4％ in China.Male breast cancer accounts for 1.9％ to 6.5％(with the mean value of 2.9％) of breast cancers in southwest of China.In China,male breast cancer is usually with poor prognosis caused by delayed diagnosis and treatment,because of being ignored by the community.It is important to strengthen the popular science propaganda,diagnosis and treatment of male breast cancer in China.
